ライフサイエンスコーパス: phosphate buffer

1 c antigen (PSA) from 1 to 1,000 nM in 100 mM phosphate buffer.

2 of detection (LOD) of 1.575 ng/mL (5 nM) in phosphate buffer.

3 n fructose and glucose solutions prepared in phosphate buffer.

4 pH, oxygen concentration and the presence of phosphate buffer.

5 itions using different organic solvents with phosphate buffer.

6 ble to compete with loss of uracil from 1 in phosphate buffer.

7 of adding a glucose solution to a potassium phosphate buffer.

8 S-ssDNA and hybridization sensing is done in phosphate buffer.

9 by disaggregation with the calcium-chelator phosphate buffer.

10 as well as with hydrogen peroxide in aqueous phosphate buffer.

11 y, were modified by incubation with iron and phosphate buffers.

12 - 0.09 and 4.6 +/- 0.7 mM measured in MES or phosphate buffers.

13 120days of storage at 4 degrees C in sodium phosphate buffer (0.1M, pH 7.5), whereas the free trypsi

14 roteins: 2.0 x10(-4) cm(3)mol/g(2) for Mb in phosphate buffer, 1.6 x10(-4) cm(3)mol/g(2) for BPTI in

15 ixture consisting in acetonitrile and sodium phosphate buffer 10mmolL(-1) pH = 3.50 (30:70v/v).

16 Phosphate buffer 44mM pH 2.5, containing 8% tetrahydrofu

17 red at -0.7 V vs Ag reference electrode in a phosphate buffer (50 mM, pH 7.0).

18 n at -0.7V vs. the Ag reference electrode in phosphate buffer (50mM, pH 6.0).

19 uffer, 1.6 x10(-4) cm(3)mol/g(2) for BPTI in phosphate buffer and 9.2 x10(-4) cm(3)mol/g(2) for BPTI

20 t CSH C18 column with gradient elution using phosphate buffer and methanol was used for their optimal

21 lpha-Cbtx, and the pellet was dissolved in a phosphate buffer and mixed with methanol for precipitati

22 inetics of murine norovirus (MNV) by PFA, in phosphate buffer and municipal secondary effluent wastew

23 The proteases were extracted with phosphate buffer and partially purified by ammonium sulp

24 fugation, and mixing of the supernatant with phosphate buffer and sodium cyanide for derivatization i

25 L/(mg.min) and 0.482 +/- 0.022 L/(mg.min) in phosphate buffer and wastewater, respectively, at pH 7.2

26 ater oxidation catalysis with involvement of phosphate buffer anions either through atom-proton trans

27 ltammetry (CV) and chronoamperometry (CA) in phosphate buffer (Argon saturated) in the absence and pr

28 cular rate constant of HNO with PY in pH 7.4 phosphate buffer at 37 degrees C can reach 8 x 10(5) M(-

29 ll cases, reactions proceeded efficiently in phosphate buffer at a physiological pH and at low substr

30 haracteristics at pH 7.5 in 100 mM potassium phosphate buffer at an applied potential of +0.250 V ver

31 ha-l- or beta-alanine and l-valine in pH 7.0 phosphate buffer at ca. 100 degrees C.

32 The sensor was calibrated for MTX in phosphate buffer at different dynamic range by varying n

33 anut, carbonate buffer at I=0.15 for almond, phosphate buffer at I=0.5 for hazelnut, and borate at I=

34 eta with incubation of complexes (0-24 h) in phosphate buffer at micromolar concentrations.

35 ent containing 40% acetonitrile (v/v), 20 mM phosphate buffer at pH 3 and 40 mM NaPF(6) using externa

36 approximately 90-mW/cm(2) illumination in a phosphate buffer at pH 7.

37 as achieved within only 2 min using 20 mM of phosphate buffer at pH 7.0 and 30 mM of sodium dodecyl s

38 on screen-printed electrode (SPE) in a 0.11M phosphate buffer at pH 7.50.

39 that of the running buffer (12.5 mmol L(-1) phosphate buffer at pH 8.5).

40 ts higher compared to bulk solution in 0.2 M phosphate buffer at potentials relevant to the formation

41 as an efficient dynamic covalent reaction in phosphate buffers at neutral pH.

42 n black particle suspension solution (pH 7.0 phosphate buffer) at varying carbon black concentrations

43 At pH 7 in phosphate buffer, BADC1 and BADC2 gain an advantage over

44 e is incubated in pH 3.0 of 0.10 M potassium phosphate buffer-based cocktail containing aniline, H2O2

45 In phosphate buffer, both APAs initially self-assembled int

46 ed strongly vitamin C degradation in citrate-phosphate buffer but not in the apple puree serum.

47 rds cardiac troponin I [1.7microA/(ng/mL) in phosphate buffer], but suffered from surface fouling in

48 we explicitly show that commonly used strong phosphate buffers cannot sustain the interfacial pH duri

49 Here, a phosphate buffer-catalyzed Pictet-Spengler reaction (PSR

50 k(PCET) is independent of phosphate buffer concentration at pH 6.5.

51 m reaction conditions were at pH 7.5 using a phosphate buffer concentration of 150 mmol l(-1) without

52 nochloramine and bromide ion concentrations, phosphate buffer concentration, and excess ammonia were

53 biocathode and GC/MWCNTs/GOx/PPy bioanode in phosphate buffer containing 10mM glucose and equal amoun

54 ight of the proteins extracted with a sodium phosphate buffer containing 2.0% sodium dodecyl sulfate

55 est results were achieved using 50 mmolL(-1) phosphate buffer containing 30 mmolL(-1) sodium dodecyl

56 treated shrimp increased significantly when phosphate buffer containing both surfactant and reducing

57 sitivity as the corresponding viral titer in phosphate buffer despite the presence of growth media an

58 ontrast, the scattering profiles for BPTI in phosphate buffer displayed substantially less pronounced

59 For the Cu(100) facet with a phosphate buffer electrolyte, the energy efficiency is f

60 one (HQ) and Hydrogen peroxide (H2O2) in PB (Phosphate Buffer) electrolyte.

61 tal microbalance (EQCM) in sulfuric acid and phosphate buffer electrolytes.

62 eved from FAU (SiO(2):Al(2)O(3) = 80:1) into phosphate buffer for 24 h followed by prolonged release

63 luted in either phosphate-buffered saline or phosphate buffer, has been widely used in studies of neu

64 meter silica nanoparticles) was incubated in phosphate buffer in the presence of the solid-phase.

65 erformance than sodium phosphate and citrate-phosphate buffers in IMAC system.

66 inactivation of B. subtilis spores in 10 mM phosphate buffer; increasing inactivation rate constants

67 This provides clear evidence that phosphate buffer is not the primary proton acceptor.

68 channel filled with citric acid and disodium phosphate buffers is investigated via numerical simulati

69 Sudan I on modified GCE was investigated in phosphate buffer medium (PBS) with various pH ranges and

70 eutral to slightly acidic pH in 10 mM sodium phosphate buffer, mitigating the concern of disassembly

71 In pH 7 phosphate buffer, Ni3S2 displays catalytic onset at 0.8

72 g the sensor combining TMB, H2O2, and GBR in phosphate buffer of pH 4.48, the S(2-) ion has effective

73 amine (GlcN, 5% w/v) was incubated in either phosphate buffer or ammonium hydroxide solutions at 40 a

74 ation of murine norovirus (MNV) by Fe(VI) in phosphate buffer (PB) and secondary effluent wastewater

75 ochloramine in secondary wastewater (WW) and phosphate buffer (PB) as assessed by reverse transcripti

76 ), or sodium nitrate (SN) solutions with 1 M phosphate buffer (PB) at different volume ratios.

77 bacteriophage in secondary effluent MWW and phosphate buffer (PB).

78 fication provided by 15 mM hydrazine in 5 mM phosphate buffer (PB; pH 7) over 100 to 300 s.

79 ate, TPPS, with Ka=3.8 10(5)mol/L in aqueous phosphate buffer pH 5.7 at 30 degrees C, and to interact

80 2O) concentrations and buffers/pH (potassium phosphate buffer pH 6-8, Tris buffer pH 8-10) on the cur

81 OCT was completely released after 300 min in phosphate buffer pH 7.4.

82 x potential at around -79 mV vs NHE in 0.1 M phosphate buffer pH 7.4.

83 these compounds at room temperature using a phosphate buffer pH 7/CD3CN mixture has shown only trace

84 performed in less than 18 min employing 20mM phosphate buffer (pH 6.5) and 150 mM SDS as background e

85 in acidic media followed by rapid release in phosphate buffer (pH 6.8).

86 e delivery of d4TTP with high selectivity in phosphate buffer (pH 7.3) and by enzyme-triggered reacti

87 Optimal signals were achieved in phosphate buffer (pH 7.4) at a flow rate of 0.5 mL min(-

88 ated with the Hg(2)(+) concentrations in the phosphate buffer (pH 7.5, 50 mM).

89 by the faster degradation of curcuminoids in phosphate buffer (pH=6.8) than in buttermilk.

90 mug muL(-1) stock solutions in 100 mM sodium phosphate buffers (pH 1-12) at room temperature.

91 lded a well-defined voltammetric response in phosphate buffer, pH 2.5 at +1.14 V (vs. Ag/AgCl) (a pre

92 , at either neutral or moderately acidic pH (phosphate buffer, pH 5) depending on the catalyst used.

93 reaction takes place under mild conditions (phosphate buffer, pH 6.5, 4 to 23 degrees C), and dissol

94 ace-confined myoglobin, in a deaerated 0.1 M phosphate buffer, pH 7.

95 duction reaction using cyclic voltammetry in phosphate buffer, pH 7.0, the immunosensor showed excell

96 are stable in physiological conditions (20mM phosphate buffer, pH 7.4, 0.14 M NaCl, 37 degrees C) and

97 y in the simulated river water samples as in phosphate buffer, reflecting its applicability to real s

98 melatonin (MEL) and nicotine (NIC) in 0.1 M phosphate buffer saline (PBS) at physiological pH of 7.

99 racies result from using inert media such as phosphate buffer saline (PBS), failing to account for th

100 25 mug mL(-1) of GOx with 5 mM glucose using phosphate buffer saline (PBS), monitored for 1 min were

101 In a mixed solvent [phosphate buffer saline (PBS), pH = 7.4/ethanol 1:9], th

102 ive layer) mainly aiming dengue diagnosis in phosphate buffer saline and blood serum environments (up

103 terminations by fixed potential amperometry, phosphate buffer saline being the best.

104 latively strong fluorescence in methanol and phosphate buffer saline in the near-infrared region (705

105 supersaturation in simulated gastric and/or phosphate buffer saline media.

106 f 1.0 mumol of TAPTA per minute in a pH 7.40 phosphate buffer saline solution containing 10% dimethyl

107 ied immunosensors, detected UCHL-1 spiked in phosphate buffer saline, artificial cerebrospinal fluid,

108 ine was examined in electrolyte solutions of phosphate buffer saline, sodium perchlorate, and in chol

109 the effect of different extraction buffers (phosphate buffer saline, Tris-HCl and NaCl) on the extra

110 ng double side tape spacer and StartingBlock phosphate buffer saline- Tween-20; (PBS-T20) blocking bu

111 ng free spaces on surface via starting block phosphate buffer saline-tween20 blocker.

112 using 0.5M NaCl as compared to Tris-HCl and phosphate buffer saline.

113 ith exchanged parameters by perfusion of the phosphate buffer saline.

114 ml x 15 ml) (n = 12) or mock challenged with phosphate buffered saline (n = 6).

115 acy increased to a higher level (~100%) when phosphate buffered saline (PBS containing 137 mM NaCl) w

116 bilized antibodies on the ZnO surface in (i) phosphate buffered saline (PBS) and (ii) human serum.

117 Detection of cTnT in phosphate buffered saline (PBS) and human serum (HS) buf

118 anging from ~10(5) to 3.2 x 10(7) CFUs/mL in phosphate buffered saline (PBS) and peritoneal dialysis

119 entrations of Immunoglobulin G (IgG) in both phosphate buffered saline (PBS) and spiked in E. coli ce

120 ns, and was found to be slowly degradable in phosphate buffered saline (PBS) but more rapidly degrade

121 ound to contain higher TPC, TFC and TCC than phosphate buffered saline (PBS) extracts for all the fru

122 t between phospholipid bilayer membranes and phosphate buffered saline (PBS) medium (DMW,PBS) for 19

123 DF-1) versus a bolus application of SDF-1 in phosphate buffered saline (PBS) on wound healing was eva

124 nanoparticles was enhanced compared to DMSO/phosphate buffered saline (PBS) or albumin/PBS solutions

125 lly captured and detected HIV-1 in serum and phosphate buffered saline (PBS) samples with viral loads

126 lin analog and the other delivered a control phosphate buffered saline (PBS) solution with no insulin

127 mplification at room temperature in 30min in phosphate buffered saline (PBS) solution.

128 Prolonged hydration in phosphate buffered saline (PBS) was found to significant

129 When phosphate buffered saline (PBS) was present in the chann

130 , we explore the effect of concentration for phosphate buffered saline (PBS), a typical ionic medium

131 lized on a gold film in both air and flowing phosphate buffered saline (PBS).

132 performed in physiological buffers, such as phosphate buffered saline (PBS).

133 R) at a diffusion-controlled rate in aerated phosphate buffered saline (PBS).

134 The films were shown to be stable in phosphate buffered saline (PBS).

135 that received either aqueous DSP solution or phosphate buffered saline (PBS).

136 release of 23% and 47% bound lactic acid in phosphate buffered saline (PBS, pH7.4) and acetate buffe

137 ately as Hg sources in washed cell assays in phosphate buffered saline (pH 7.4), we report how cell-m

138 d as OP(*OH)) from both Fe(II) and Cu(II) in phosphate buffered saline (pH 7.40) containing ascorbic

139 in vivo compared to in vitro using agitated phosphate buffered saline +0.02% Tween 80 pH7.4, includi

140 tion limits of 1 pM and 10 pM of thrombin in phosphate buffered saline and mimic serum solution, resp

141 at 10 and 30 pg/mL level was demonstrated in phosphate buffered saline and serum, respectively.

142 approximately 5fg/ml for assays conducted in phosphate buffered saline buffer (PBS) and approximately

143 nhancer of viral infection fibrils formed in phosphate buffered saline keep evolving after the initia

144 In phosphate buffered saline medium the actual lipophilicit

145 Control nonischemic limbs were injected with phosphate buffered saline or remained noninjected.

146 d detection of E. coli in buffered solution (phosphate buffered saline solution).

147 Control animals were treated with a phosphate buffered saline vehicle while the other group

148 unction studies, recombinant IL-7 or control phosphate buffered saline was injected intraperitoneally

149 Given time, most of the assemblies in phosphate buffered saline will turn into elongated thin

150 in a complex matrix (bovine serum albumin in phosphate buffered saline) is also demonstrated through

151 obtained compared to result obtained in PBS (phosphate buffered saline).

152 .0078mg/ml of T24 (Grade III) cell lysate in phosphate buffered saline, artificial urine and human ur

153 cross-sections of brushite cylinders aged in Phosphate Buffered Saline, Foetal Bovine Serum, Dulbecco

154 ry and the differential pulse voltammetry in phosphate buffered saline, pH = 7.0.

155 In the phosphate buffered saline-treated animals, human skin al

156 3-treated P. gingivalis-infected mice versus phosphate buffered saline-treated P. gingivalis-infected

157 25 head and neck squamous carcinoma cells in phosphate buffered saline.

158 specific and little non-specific binding in phosphate buffered saline.

159 tection limit of 500 muM in water and 1mM in phosphate buffered saline.

160 tuses fixed overnight in 4% paraformaldehyde/phosphate buffered saline.

161 Outflow facility for phosphate-buffered saline (0.0027 +/- 0.00036 muL/min/mm

162 e injected with BM-MSCs, AT-MSCs, or vehicle-phosphate-buffered saline (Control) 2 weeks post-defect

163 cells at room temperature or 4 degrees C in phosphate-buffered saline (labeling efficiency range, 13

164 In the presence of 5 mM glucose in phosphate-buffered saline (PBS) (50 mM phosphate buffer

165 n conjunctival fibroblasts were incubated in phosphate-buffered saline (PBS) (control), MMC (0.2 mg/m

166 d in 50 mg/mL TCN solution (experimental) or phosphate-buffered saline (PBS) (control).

167 aryngeally aspirated 200 ug of WTC-PM(53) or phosphate-buffered saline (PBS) (controls).

168 subunit (CTB) or heat-labile toxin (LTB), or phosphate-buffered saline (PBS) alone and then challenge

169 n of the brain with cold or room temperature phosphate-buffered saline (PBS) also caused significant

170 d -25 degrees C for at least 3 days by using phosphate-buffered saline (PBS) and cysteine/methionine-

171 determination of prohibited substances from phosphate-buffered saline (PBS) and human urine using Fe

172 The detection curves were obtained in phosphate-buffered saline (PBS) and in undiluted artific

173 niae were treated intravenously with PFCE or phosphate-buffered saline (PBS) and then managed in eith

174 tal recoveries obtained for all compounds in phosphate-buffered saline (PBS) and urine samples owing

175 bats with one of four vaccine treatments or phosphate-buffered saline (PBS) as a control and challen

176 es for the detection of nitric oxide (NO) in phosphate-buffered saline (PBS) at pH 7.4.

177 were injected with cultured mast cells or 1x phosphate-buffered saline (PBS) before collecting serum,

178 at generated by bare carbon nanotube yarn in phosphate-buffered saline (PBS) buffer.

179 ignificant reduction of diarrhea compared to phosphate-buffered saline (PBS) controls (PE = 84.1%; P

180 A plus Vaxfectin i.m. or 100 mug of DNA plus phosphate-buffered saline (PBS) i.m. using a needleless

181 in the presence of succinate, fumarate, and phosphate-buffered saline (PBS) in different cell models

182 technique for cell-free virus elution using phosphate-buffered saline (PBS) may provide an alternati

183 animals used as controls were injected with phosphate-buffered saline (PBS) or GBV-B, respectively.

184 ue-Dawley rats, 2 microg rhTSG-6 in 5-microL phosphate-buffered saline (PBS) or the same volume of on

185 plification was achieved through dilution of phosphate-buffered saline (PBS) to tune Cdl to dominate

186 ll crowd and then extracted with ~0.5 muL of phosphate-buffered saline (PBS) via pipet immediately af

187 to 400 mg/dL or 0.10-10.34 mmol/L in 100 mM phosphate-buffered saline (PBS) without significant inte

188 hat C. neoformans grown with IgM, not IgG or phosphate-buffered saline (PBS), had decreased expressio

189 ibodies (mAbs) and ADCs, such as nonvolatile phosphate-buffered saline (PBS), should be replaced befo

190 were attained for all the studied probes in phosphate-buffered saline (PBS), urine, and whole blood.

191 ere surface-inoculated with P. aeruginosa in phosphate-buffered saline (PBS), while sterile PBS was u

192 ferritin Ab-functionalized microparticles in phosphate-buffered saline (PBS).

193 tions of VIPhyb (peptidic VIP-antagonist) or phosphate-buffered saline (PBS).

194 ne injections of lipopolysaccharide (LPS) or phosphate-buffered saline (PBS).

195 Control mice received phosphate-buffered saline (PBS).

196 iRNA-21 in the range from 10 pM to 100 nM in phosphate-buffered saline (PBS); the limit of detection

197 obiota in two frequently used batch systems: phosphate-buffered saline (PBS, oligotrophic) and basal

198 Control animals received phosphate-buffered saline (PBS; n = 5 to 7).

199 reported affinity for a cryptophane host in phosphate-buffered saline (pH 7.2).

200 Four groups were studied: sham and SCI plus phosphate-buffered saline (SCI + PBS), human embryonic k

201 usion of either human recombinant decorin or phosphate-buffered saline (vehicle).

202 BALB/c mice received LAIV or phosphate-buffered saline 1 or 7 days before or during p

203 RMG (but not in those vaccinated with REG or phosphate-buffered saline [PBS]) after homologous or het

204 antibody pair detects PA(83) down to 1 nM in phosphate-buffered saline and 5 nM in human serum, which

205 d 2-[(131) I] exhibit good stability in both phosphate-buffered saline and blood serum.

206 ntly enhanced analytical performance in both phosphate-buffered saline and plasma (6-20x improvement

207 thod is approximately 1 IU/mL (2 nM) in both phosphate-buffered saline and urine samples, and only 0.

208 ells were formed into pellets and covered in phosphate-buffered saline at room temperature for 56 h.

209 et for 12 weeks, then administered rIL-19 or phosphate-buffered saline concomitant with Western diet

210 The aerosol particles were then dispersed in phosphate-buffered saline for cytotoxicity and senescenc

211 TNNB1-LNP), scrambled sequence (Scr-LNP), or phosphate-buffered saline for multiple cycles.

212 estoration of urothelial layers, whereas the phosphate-buffered saline group had ongoing regeneration

213 were compared with those of single agents or phosphate-buffered saline in a Raji2R-xenograft model.

214 human amniotic mesenchymal stromal cells or phosphate-buffered saline infused intracerebroventricula

215 mucosa between the molars; and 6) group I-V: phosphate-buffered saline injected into the palatal muco

216 thogenic Escherichia coli (MG1655 strain) or phosphate-buffered saline into the urethra of mice led t

217 Mouse IgG diluted in phosphate-buffered saline is used as model target antige

218 assembly by injection from THF solution into phosphate-buffered saline led to unilamellar, monodisper

219 e injected i.p. with 50 or 250 mg/kg APAP or phosphate-buffered saline on gestation day 12.5; nonpreg

220 individuals by the oral route, mice were fed phosphate-buffered saline or 10(6)M. canettii mycobacter

221 Phosphate-buffered saline or iPSC-w/o-c-Myc was then int

222 Formaldehyde, diluted in either phosphate-buffered saline or phosphate buffer, has been

223 e, which were challenged with OVA peptide or phosphate-buffered saline or remained untreated.

224 ed with either bone marrow-derived MSCs or a phosphate-buffered saline placebo via direct intraventri

225 ily dissociated from the graft surface after phosphate-buffered saline rinsing.

226 ide, and the ECL of the 1a film was found in phosphate-buffered saline solution with TPrA.

227 versibility of PRET upon the introduction of phosphate-buffered saline to the channel.

228 tacept (CTLA4-Ig), etanercept (anti-TNF), or phosphate-buffered saline were given to NMRI mice intrav

229 o hundred thousand cells suspended in 20 muL phosphate-buffered saline were mixed with 200 muL Matrig

230 er-resolution microscopy was demonstrated in phosphate-buffered saline without any reducing or oxidiz

231 iae (1,500 colony-forming units) or vehicle (phosphate-buffered saline) at 3 or 60 days post-injury.

232 domized to a single IV injection of vehicle (phosphate-buffered saline) or suppressor of site IQ elec

233 wth and prolonged median survival from 13 d (phosphate-buffered saline) to 20 and 29 d for DAR2 and D

234 In vehicle (phosphate-buffered saline)-pretreated mice, nonapoptotic

235 Median survival for the groups treated with phosphate-buffered saline, 6 MBq (213)Bi-IMP288, 12 MBq

236 omers enables robust cross-linking in water, phosphate-buffered saline, and cell culture medium to af

237 temically administered (64)CuCl2 (74 MBq) or phosphate-buffered saline, and tumor sizes were monitore

238 d stability of these probes were assessed in phosphate-buffered saline, cell culture medium, rat seru

239 emotherapy alone, RF hyperthermia alone, and phosphate-buffered saline, combination therapy with RF h

240 emotherapy alone, RF hyperthermia alone, and phosphate-buffered saline, combination therapy with RF h

241 othelial cells, n = 4) or control treatment (phosphate-buffered saline, n = 4) by means of imaging-gu

242 s (6.1 +/- 0.5 %ID/cm(3)) when compared with phosphate-buffered saline-challenged animals (4.6 +/- 0.

243 tumor growth compared with mice treated with phosphate-buffered saline-containing liposomes (P<0.001)

244 atment groups were compared with age-matched phosphate-buffered saline-injected control transgenic an

245 led animals receiving intravenous vehicle or phosphate-buffered saline-instilled animals receiving me

246 with parstatin compared to their respective phosphate-buffered saline-treated controls.

247 improve muscle regeneration, laminin-111 or phosphate-buffered saline-treated laminin-alpha2-deficie

248 antibody-treated animals lived, whereas 3/8 phosphate-buffered saline-treated mice died.

249 D45(+) cells in the prostates of E. coli- or phosphate-buffered saline-treated mice.

250 were intratracheally instilled with sterile phosphate-buffered saline.

251 py alone, (c) RF hyperthermia alone, and (d) phosphate-buffered saline.

252 q of (212)Pb-daratumumab instead of 11 d for phosphate-buffered saline.

253 eached as low as 3.5x10(1)CFUmL(-1) in 0.01M phosphate-buffered saline.

254 erapy only, (c) RF hyperthermia only, or (d) phosphate-buffered saline.

255 h; sham controls received an equal volume of phosphate-buffered saline.

256 ce treated with a scrambled-sequence PPMO or phosphate-buffered saline.

257 in all groups were agitated for 3 minutes in phosphate-buffered saline.

258 /kg) for 3 weeks, while 10 controls received phosphate-buffered saline.

259 for culture of mammalian and yeast cells and phosphate-buffered saline.

260 and 0.69 V, as a result of the diffusion of phosphate-buffered saline.

261 omic shift of 115 nm on changing from THF to phosphate-buffered saline.

262 alone (200 million cells, n=5), or placebo (phosphate-buffered saline; n=5) was injected into the in

263 56days in various media: pH5.5, 6.5, and 7.4 phosphate buffered-saline (PBS) containing 0.02% Tween 8

264 ms well for the quantification of glucose in phosphate buffer solution (0.25M PBS, pH 7.0), with a li

265 All the experiments were carried out in 0.1M phosphate buffer solution (PBS) at pH 7.0 and 0.1M KCl s

266 ) was applied for IMQ determination in 0.1 M phosphate buffer solution (PBS) at pH 7.0.

267 Ru(NH3)6(3+), and anionic Fe(CN)6(4-)) in a phosphate buffer solution (PBS) containing AFB1, the mag

268 ction of reduced glutathione (GSH) in pH 7.2 phosphate buffer solution (PBS) has been reported.

269 (E(0)) of -0.471 V (vs. Ag/AgCl) in a pH 6.5 phosphate buffer solution (PBS).

270 sociation with bovine serum albumin (BSA) in phosphate buffer solution (PBS).

271 at a current density of 10 mA cm(-2) in 1 m phosphate buffer solution (PBS, pH 7.0).

272 Glucose sensing accomplished in a phosphate buffer solution (PBS, pH=7) for ZnO/MWCNT/GCE

273 ity for the oxidation of L-cysteine in 0.1 M phosphate buffer solution (pH 5.0).

274 9 cycles in the presence of 80 mM pyrrole in phosphate buffer solution (pH 6.0) containing 20mM CEF.

275 ivity towards the oxidations of AT and VC in phosphate buffer solution (pH 7.0) and the corresponding

276 t from CNTs to 7.4 atom % N-CNTs in a sodium phosphate buffer solution (pH 7.0) with 2.0 mM NADH (sca

277 ith 2U of GALOX, at 35 degrees C, using 50mM phosphate buffer solution (pH 7.0).

278 photolysis of the chosen aromatic in aqueous phosphate buffer solution (pH = 7.3), with the consecuti

279 from 0.2 to 1.3V using CV and DPV methods in phosphate buffer solution with pH 2.0.

280 Omega) = 14 mOmega m(2)) (acetate in a 50 mM phosphate buffer solution).

281 se in phosphate-buffered saline (PBS) (50 mM phosphate buffer solution, pH 7.4, with 150 mM NaCl), hi

282 centration range of 30.4 and 243.9 microM in phosphate buffer solution, with a corresponding limit of

283 explored by the electrochemical approach in phosphate buffer solution.

284 dified glassy carbon electrode (MWNT/GCE) in phosphate buffer solution.

285 PEC) for sustained water splitting in a pH 7 phosphate buffer solution.

286 (GC-Nf-B-3Nf) film modified GCE in a pH 3.5 phosphate buffer solution.

287 ation was observed in organic solvents or in phosphate buffer solution.

288 In phosphate-buffered solution, cis-4-fluoroproline is more

289 immune deficiency virus) antibodies (Ab) in phosphate buffered solutions (PBS).

290 imaging (MFI) during freeze-thaw cycling in phosphate buffered solutions.

291 nt (kexp) found in both 1 mM NaHCO3 and 1 mM phosphate-buffered solutions suggested that OH radical w

292 ate) (ABTS) and self-decay of ferrate(VI) in phosphate-buffered solutions.

293 ridine) and Na2S2O8, in acetonitrile/aqueous phosphate buffer takes place with a quantum yield of 0.2

294 genise and heat samples in an SDS-containing phosphate buffer to dissolve major muscle components and

295 NADH degradation, known to occur in phosphate buffer, was characterized by absorbance at 340

296 and ferric chloride addition in borate- and phosphate-buffered waters showed that phosphate could se

297 Replacing the phosphate buffer with 3-(N-morpolino)propane sulfonic ac

298 osensor response for both samples diluted in phosphate buffer with a higher limit of detection for th

299 to 0.10 muM bilirubin, measured in a sodium phosphate buffer with pH 8.6) covers the clinically-rele

300 he freeze dried product in Mcllvaine citrate-phosphate buffers with pH values of 3-5 and temperatures